Search details
1.
T-cell lymphoma: the CAR-T revolution is coming.
Blood
; 143(13): 1201-1202, 2024 Mar 28.
Article
in English
| MEDLINE | ID: mdl-38546636
2.
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
Lancet Oncol
; 18(2): 230-240, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-28089635
3.
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
Eur Heart J
; 37(4): 412-22, 2016 Jan 21.
Article
in English
| MEDLINE | ID: mdl-26637834
4.
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Br J Haematol
; 172(4): 535-44, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26627450
5.
Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
Cancer Invest
; 34(6): 279-85, 2016 Jul 02.
Article
in English
| MEDLINE | ID: mdl-27379565
6.
Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study.
Br J Haematol
; 184(4): 647-650, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29468651
7.
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Br J Haematol
; 166(1): 77-83, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24661044
8.
Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy.
Oncology (Williston Park)
; 28(12): 1074-81, 1084, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25510806
9.
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study.
Lancet Haematol
; 11(5): e358-e367, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38555923
10.
Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL).
Cancer
; 119(21): 3788-96, 2013 Nov 01.
Article
in English
| MEDLINE | ID: mdl-23922059
11.
The optimal management of relapsed and refractory Hodgkin lymphoma: post-brentuximab and checkpoint inhibitor failure.
Hematology Am Soc Hematol Educ Program
; 2023(1): 510-518, 2023 Dec 08.
Article
in English
| MEDLINE | ID: mdl-38066906
12.
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas.
J Immunother Cancer
; 11(8)2023 08.
Article
in English
| MEDLINE | ID: mdl-37527906
13.
Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks.
Oncology (Williston Park)
; 26(12): 1182-9, 1193, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23413599
14.
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.
J Geriatr Oncol
; 13(2): 258-264, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34686472
15.
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma.
Blood Adv
; 6(4): 1255-1263, 2022 02 22.
Article
in English
| MEDLINE | ID: mdl-34666347
16.
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
Blood Adv
; 6(7): 2035-2044, 2022 04 12.
Article
in English
| MEDLINE | ID: mdl-35196377
17.
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.
Cancer Invest
; 29(3): 214-9, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-21314330
18.
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma.
Leuk Lymphoma
; 62(1): 68-75, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32935601
19.
Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma.
Exp Hematol Oncol
; 10(1): 15, 2021 Feb 18.
Article
in English
| MEDLINE | ID: mdl-33602316
20.
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation.
Leuk Lymphoma
; 62(1): 86-94, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32933363